| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.14 | 0.5 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |